Skip to main content
Top
Published in: Clinical Rheumatology 6/2015

01-06-2015 | Original Article

Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease

Author: James T. Rosenbaum

Published in: Clinical Rheumatology | Issue 6/2015

Login to get access

Abstract

Uveitis is a common complication of spondyloarthritis. The “phenotype” of the uveitis characteristic of ankylosing spondylitis (sudden onset, anterior, unilateral, recurrent, more often male) may differ from the phenotype often seen with either psoriatic arthritis or inflammatory bowel disease (insidious onset, anterior and intermediate, bilateral, chronic, and/or more often female). The frequency of uveitis is also much greater in association with ankylosing spondylitis than with either inflammatory bowel disease or psoriasis. Uveitis may affect the choice of therapy and can rarely be a complication of therapy. Uveitis and arthritis also co-exist in several animal models.
Literature
1.
go back to reference Rosenbaum J, Chandran V (2012) Management of comorbidities in ankylosing spondylitis. Am J Med Sci 343(5):364–366CrossRefPubMed Rosenbaum J, Chandran V (2012) Management of comorbidities in ankylosing spondylitis. Am J Med Sci 343(5):364–366CrossRefPubMed
2.
3.
go back to reference Lyons JL, Rosenbaum JT (1997) Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 115:61–64CrossRefPubMed Lyons JL, Rosenbaum JT (1997) Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 115:61–64CrossRefPubMed
4.
go back to reference Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509–516CrossRefPubMed Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509–516CrossRefPubMed
5.
go back to reference Rosenbaum JT (1989) Characterization of uveitis associated with spondyloarthritis. J Rheumatol 16(6):792–796PubMed Rosenbaum JT (1989) Characterization of uveitis associated with spondyloarthritis. J Rheumatol 16(6):792–796PubMed
6.
go back to reference Sampaio-Barros PD, Conde RA, Bonfiglioli R, Bertolo MB, Samara AM (2006) Characterization and outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol Int 26(12):1143–1146CrossRefPubMed Sampaio-Barros PD, Conde RA, Bonfiglioli R, Bertolo MB, Samara AM (2006) Characterization and outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol Int 26(12):1143–1146CrossRefPubMed
7.
go back to reference D'Alessandro LP, Forster DJ, Rao NA (1991) Anterior uveitis and hypopyon. Am J Ophthalmol 112:317–321CrossRefPubMed D'Alessandro LP, Forster DJ, Rao NA (1991) Anterior uveitis and hypopyon. Am J Ophthalmol 112:317–321CrossRefPubMed
8.
go back to reference Zeboulon N, Dougados M, Gossec L (2008) Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis 67(7):955–959CrossRefPubMed Zeboulon N, Dougados M, Gossec L (2008) Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis 67(7):955–959CrossRefPubMed
9.
go back to reference Wright R, Lumsden K, Luntz MH, Sevel D, Truelove SC (1965) Abnormalities of the sacro-iliac joints and uveitis in ulcerative colitis. Q J Med 34:229–236PubMed Wright R, Lumsden K, Luntz MH, Sevel D, Truelove SC (1965) Abnormalities of the sacro-iliac joints and uveitis in ulcerative colitis. Q J Med 34:229–236PubMed
10.
go back to reference Greenstein AJ, Janowitz HD, Sachar DB (1976) The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 55(5):401–412CrossRef Greenstein AJ, Janowitz HD, Sachar DB (1976) The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 55(5):401–412CrossRef
11.
go back to reference Yilmaz S, Aydemir E, Maden A, Unsal B (2007) The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis 22(9):1027–1030CrossRefPubMed Yilmaz S, Aydemir E, Maden A, Unsal B (2007) The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis 22(9):1027–1030CrossRefPubMed
12.
go back to reference Lanna CC, Ferrari Mde L, Rocha SL, Nascimento E, de Carvalho MA, da Cunha AS (2008) A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations. Clin Rheumatol 27(4):503–509CrossRefPubMed Lanna CC, Ferrari Mde L, Rocha SL, Nascimento E, de Carvalho MA, da Cunha AS (2008) A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations. Clin Rheumatol 27(4):503–509CrossRefPubMed
13.
go back to reference Felekis T, Katsanos K, Kitsanou M et al (2009) Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis 15(1):29–34CrossRefPubMed Felekis T, Katsanos K, Kitsanou M et al (2009) Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis 15(1):29–34CrossRefPubMed
14.
go back to reference Niccoli L, Nannini C, Cassara E et al (2012) Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Int J Rheum Dis 15(4):414–418CrossRefPubMed Niccoli L, Nannini C, Cassara E et al (2012) Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Int J Rheum Dis 15(4):414–418CrossRefPubMed
16.
go back to reference Robinson PC, Claushuis TA, Cortes A et al (2015) Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis Rheum 67(1):140–151CrossRef Robinson PC, Claushuis TA, Cortes A et al (2015) Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis Rheum 67(1):140–151CrossRef
17.
go back to reference Martin TM, Zhang G, Luo J et al (2005) A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum 52(1):269–274CrossRefPubMed Martin TM, Zhang G, Luo J et al (2005) A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum 52(1):269–274CrossRefPubMed
18.
go back to reference Braun J, Baraliakos X, Listing J, Sieper J (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52(8):2447–2451CrossRefPubMed Braun J, Baraliakos X, Listing J, Sieper J (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52(8):2447–2451CrossRefPubMed
19.
go back to reference Wendling D, Paccou J, Berthelot JM et al (2011) New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases. Semin Arthritis Rheum 41(3):503–510CrossRefPubMed Wendling D, Paccou J, Berthelot JM et al (2011) New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases. Semin Arthritis Rheum 41(3):503–510CrossRefPubMed
20.
go back to reference Rudwaleit M, Rodevand E, Holck P et al (2009) Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis 68(5):696–701CrossRefPubMedCentralPubMed Rudwaleit M, Rodevand E, Holck P et al (2009) Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis 68(5):696–701CrossRefPubMedCentralPubMed
21.
go back to reference Galor A, Perez V, Hammel J, Lowder C (2006) Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology 113(12):2137–2323CrossRef Galor A, Perez V, Hammel J, Lowder C (2006) Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology 113(12):2137–2323CrossRef
22.
go back to reference Munoz-Fernandez S, Hidalgo V, Fernandez-Melon J et al (2003) Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period. J Rheumatol 30(6):1277–1279PubMed Munoz-Fernandez S, Hidalgo V, Fernandez-Melon J et al (2003) Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period. J Rheumatol 30(6):1277–1279PubMed
23.
go back to reference Dougados M, Berenbaum F, Maetzel A, Amor B (1993) Prevention of acute anterior uveitis associated with spondyloarthropathy induced by salazosulfapyridine. Rev Rhum 60:81–83 Dougados M, Berenbaum F, Maetzel A, Amor B (1993) Prevention of acute anterior uveitis associated with spondyloarthropathy induced by salazosulfapyridine. Rev Rhum 60:81–83
24.
go back to reference Munoz-Fernandez S, Garcia-Aparicio AM, Hidalgo MV et al (2009) Methotrexate: an option for preventing the recurrence of acute anterior uveitis. Eye (Lond) 23(5):1130–1133CrossRef Munoz-Fernandez S, Garcia-Aparicio AM, Hidalgo MV et al (2009) Methotrexate: an option for preventing the recurrence of acute anterior uveitis. Eye (Lond) 23(5):1130–1133CrossRef
25.
go back to reference Levinson RD, Rosenbaum JT (2010) Nonsteroidal anti-inflammatory drugs for prophylaxis of acute anterior uveitis. Ocul Immunol Inflamm 18(2):69–71CrossRefPubMed Levinson RD, Rosenbaum JT (2010) Nonsteroidal anti-inflammatory drugs for prophylaxis of acute anterior uveitis. Ocul Immunol Inflamm 18(2):69–71CrossRefPubMed
26.
go back to reference Lim LL, Fraunfelder FW, Rosenbaum JT (2007) Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 56(10):3248–3252CrossRefPubMed Lim LL, Fraunfelder FW, Rosenbaum JT (2007) Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 56(10):3248–3252CrossRefPubMed
27.
go back to reference Kezic JM, Glant TT, Rosenbaum JT, Rosenzweig HL (2012) Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis. Arthritis Res Ther 14(1):R18CrossRefPubMedCentralPubMed Kezic JM, Glant TT, Rosenbaum JT, Rosenzweig HL (2012) Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis. Arthritis Res Ther 14(1):R18CrossRefPubMedCentralPubMed
28.
go back to reference Kezic JM, Davey MP, Glant TT, Rosenbaum JT, Rosenzweig HL (2012) Interferon-gamma regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis. Arthritis Rheum 64(3):762–771CrossRefPubMedCentralPubMed Kezic JM, Davey MP, Glant TT, Rosenbaum JT, Rosenzweig HL (2012) Interferon-gamma regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis. Arthritis Rheum 64(3):762–771CrossRefPubMedCentralPubMed
29.
go back to reference Petty RE, Johnston W, McCormick AQ, Hunt DWC, Rootman J, Rollins DF (1989) Uveitis and arthritis induced by adjuvant: clinical, immunologic and histologic characteristics. J Rheumatol 16:499–505PubMed Petty RE, Johnston W, McCormick AQ, Hunt DWC, Rootman J, Rollins DF (1989) Uveitis and arthritis induced by adjuvant: clinical, immunologic and histologic characteristics. J Rheumatol 16:499–505PubMed
30.
go back to reference Ruutu M, Thomas G, Steck R et al (2012) Beta-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice. Arthritis Rheum 64(7):2211–2222CrossRefPubMed Ruutu M, Thomas G, Steck R et al (2012) Beta-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice. Arthritis Rheum 64(7):2211–2222CrossRefPubMed
31.
go back to reference Baggia S, Lyons J, Angell E et al (1997) A novel model of bacterially-induced acute anterior uveitis in rats and the lack of effect from HLA B27 expression. J Investig Med 45:295–301PubMed Baggia S, Lyons J, Angell E et al (1997) A novel model of bacterially-induced acute anterior uveitis in rats and the lack of effect from HLA B27 expression. J Investig Med 45:295–301PubMed
Metadata
Title
Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease
Author
James T. Rosenbaum
Publication date
01-06-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 6/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-2960-8

Other articles of this Issue 6/2015

Clinical Rheumatology 6/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.